Efficacy and Safety of the Mammalian Target of Rapamycin (mTor Rapamycin) Inhibitor in Vascular Malformations
Clinical trial NCT01811667 · COMPLETED
Trial details
- NCT number
- NCT01811667
- Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2016-01-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.